Cell line · CVCL_1926
Papers131
177 more articles give this line's RRID in its Methods without naming the line nearby, so they are not listed.
1 to 20 of 131
Download this page as JSON| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Immunogenicity and protective efficacy of single-dose adenoviral vaccines expressing Crimean-Congo haemorrhagic fever virus GP38, Gc, or nucleoprotein antigens in mice: a preclinical study. | EBioMedicine | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Nrf2 and STAT3 Pathways in Protecting Against Methylmercury-Induced Oxidative Stress in Hypothalamic Neuronal GT1-7 Cells. | Neurochem Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| ATP13A4 gates extracellular polyamine levels to control excitatory synaptogenesis. | Nat Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Ptpn2 limits plasma cell fate and antiviral immunity by integrating B cell receptor and IFN-γ signals in B cells. | Sci Adv | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Canonical Antibodies Adopt Distinct Binding Modes to Recognize Viral Glycan Shields. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Importin 7 mediates the nuclear import of HIV-1 integrase via a specific interacting interface. | FEBS Open Bio | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Intrathecal Allogeneic B7-H3-Targeted CAR γδ T Cells for Leptomeningeal Metastasis from Solid Tumors: Safety, Efficacy, and Immunologic Dynamics in a Phase I Trial. | Clin Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A Single-Chain Light-Activatable Transcriptional Reporter for Fluorescently Tagging Mammalian Cells In Vitro. | Chembiochem | 2026 | Its Methods give the RRID and name the line | PubMed | |
| HIV broadly neutralizing antibody escape dynamics drive the outcome of AAV-vectored immunotherapy in humanized mice. | Immunity | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Structure-Based Discovery of Obeticholic Acid Derivatives as Novel Farnesoid X Receptor Partial Agonists with Improved Selectivity and Reduced Off-Target Effects. | ChemMedChem | 2026 | Its Methods give the RRID and name the line | PubMed | |
| METTL3 promotes neutrophil extracellular trap formation via SYK/ERK/MEK signaling during acute lung injury. | J Adv Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeting TRIM25 as a therapeutic strategy to enhance ferroptosis in glioblastoma cells. | J Nanobiotechnology | 2026 | Its Methods give the RRID and name the line | PubMed | |
| RNF13 is a previously undescribed interactor of iduronate 2-sulfatase that modifies its glycosylation and maturation. | FEBS J | 2026 | Its Methods give the RRID and name the line | PubMed | |
| PCSK5M452I Is a Recessive Hypomorph Exclusive to MCF10DCIS.com Cells. | Mol Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| SS18::SSX and BRD9 Modulate Synovial Sarcoma Differentiation. | Cells | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Stimulation of Ca2+ channel CaV1.2 activity by dopamine signaling augments spatial working memory. | Sci Signal | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Endolysosomal dysfunction impairs proteostasis and induces neurodegeneration in vivo. | iScience | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Designing allosteric modulators to change GPCR G protein subtype selectivity. | Nature | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Directed-complement killing of Pseudomonas aeruginosa protects against lethal pneumonia. | EBioMedicine | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Serotonin 5-HT2C Receptor Signaling Analysis Reveals Psychedelic Biased Agonism. | ACS Chem Neurosci | 2025 | Its Methods give the RRID and name the line | PubMed |
cell-lines-2026-11-14-0.1.0
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_1926/papers